Transcend Capital Advisors LLC Purchases 5,428 Shares of CVS Health Corporation (NYSE:CVS)

Transcend Capital Advisors LLC lifted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 38.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,382 shares of the pharmacy operator's stock after purchasing an additional 5,428 shares during the period. Transcend Capital Advisors LLC's holdings in CVS Health were worth $1,313,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Hopwood Financial Services Inc. bought a new position in CVS Health in the fourth quarter worth approximately $29,000. McIlrath & Eck LLC increased its stake in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. MV Capital Management Inc. raised its holdings in CVS Health by 63.9% in the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 289 shares during the period. Dunhill Financial LLC lifted its position in CVS Health by 147.2% during the first quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock valued at $51,000 after purchasing an additional 446 shares in the last quarter. Finally, Atwood & Palmer Inc. grew its holdings in CVS Health by 228.0% during the first quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 570 shares during the period. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on CVS shares. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Robert W. Baird raised their price target on CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Royal Bank Of Canada boosted their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Activity

In other news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.22% of the company's stock.

CVS Health Trading Up 0.5%

Shares of CVS opened at $68.50 on Friday. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The company's fifty day moving average is $64.86 and its 200 day moving average is $60.79. The stock has a market capitalization of $86.66 billion, a PE ratio of 16.35, a P/E/G ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.